Among the related lncRNAs, MEG3 was confirmed to be lowly expressed in female-related tumors, and as a tumor suppressor to inhibit the malignant progression of cancer cells in vitro and in vivo[21,22]. This evidence concerns the gene MEG3 and neoplasm.